.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Star Health financial growth reached a new peak as the insurer reported a net profit of Rs 111 crore. This multi-fold jump occurred during the fourth quarter ending March 2026. However, the company recorded a mere Rs 50 lakh profit in the same quarter last year. Consequently, the firm showed a significant recovery in its financial performance. Total income increased to Rs 4,545 crore from Rs 3,989 crore during the reporting period.
Gross written premiums rose to Rs 5,968 crore against Rs 5,138 crore in the year-ago period. Furthermore, net premiums increased to Rs 5,599 crore from Rs 4,820 crore. Additionally, the company focused on its retail health portfolio to drive sustainable margins. This strategy helped improve the combined ratio to 95.7% during the quarter. Therefore, medical professionals should note the insurer's improving stability for claim settlements.
Underwriting losses significantly dropped to Rs 154 crore from Rs 275 crore in the prior year. Moreover, the insurer settled approximately 30 lakh claims during the full financial year 2026. Total payouts for these claims exceeded Rs 11,900 crore. Specifically, the retail loss ratio saw a decline, reflecting better risk selection. Since doctors rely on timely insurance payments, these metrics indicate a positive operational trend.
Q1: What was Star Health's net profit in the final quarter of FY26?
The company reported a net profit of Rs 111 crore, which is a massive increase from the Rs 50 lakh profit reported in the same quarter of the previous year.
Q2: How did the underwriting loss change compared to the previous year?
The underwriting loss narrowed to Rs 154 crore from Rs 275 crore, indicating more disciplined risk management and better operational efficiency.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Star Health reported a net profit jump to Rs 111 crore in Q4 FY26, driven by premium growth and reduced underwriting losses in the health sector....
4 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
